Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Malignant Lymphoma

  Free Subscription


17.04.2023

1 Am J Clin Pathol
1 Am J Hematol
1 Blood
1 Br J Haematol
1 Cancer
1 Eur J Immunol
1 Haematologica
1 Hum Pathol
1 J Clin Oncol
1 Leuk Lymphoma
3 Leukemia
1 N Engl J Med
1 Oncol Rep


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. CZADER M, Amador C, Cook JR, Thakkar D, et al
    Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop.
    Am J Clin Pathol. 2023 Apr 13:aqad027. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  2. HUNTINGTON SF, Schuster SJ, Ding W, Koehler AB, et al
    DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study.
    Am J Hematol. 2023;98:739-749.
    PubMed         Abstract available


    Blood


  3. Tong C, Zhang Y, Liu Y, et al. Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma. Blood. 2020;136(14):1632-1644.
    Blood. 2023;141:1896.
    PubMed        


    Br J Haematol

  4. LE GOFF E, Blanc-Durand P, Roulin L, Lafont C, et al
    Baseline circulating tumour DNA and total metabolic tumour volume as early outcome predictors in aggressive large B-cell lymphoma. A real-world 112-patient cohort.
    Br J Haematol. 2023 Apr 10. doi: 10.1111/bjh.18809.
    PubMed         Abstract available


    Cancer

  5. QUEUDEVILLE M, Stein AS, Locatelli F, Ebinger M, et al
    Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
    Cancer. 2023 Feb 24. doi: 10.1002/cncr.34667.
    PubMed         Abstract available


    Eur J Immunol

  6. GUPTA DD, Lohoff M
    Puppet masters of b cell progenitor acute lymphoblastic leukemia: the preb cell receptor and the interleukin 7 receptor alpha.
    Eur J Immunol. 2023 Feb 20:e2250093. doi: 10.1002/eji.202250093.
    PubMed         Abstract available


    Haematologica

  7. MOONLA C, Polprasert C, Komvilaisak P, Rattanathammethee T, et al
    Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.
    Haematologica. 2023 Apr 13. doi: 10.3324/haematol.2022.282419.
    PubMed         Abstract available


    Hum Pathol

  8. KIM H, Shin D, Son SM, Cho J, et al
    Clinicopathological and molecular genetic characteristics of primary gastric follicular lymphoma(☆,☆☆,☆☆☆).
    Hum Pathol. 2023 Apr 11:S0046-8177(23)00086.
    PubMed         Abstract available


    J Clin Oncol


  9. Erratum: Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice.
    J Clin Oncol. 2023 Apr 11:JCO2300633. doi: 10.1200/JCO.23.00633.
    PubMed        


    Leuk Lymphoma

  10. NG WL, Wang Y, Bock AM, Jevremovic D, et al
    Review of management options for mantle cell lymphoma in pregnancy.
    Leuk Lymphoma. 2023 Apr 10:1-5. doi: 10.1080/10428194.2023.2196592.
    PubMed        


    Leukemia

  11. ARAUJO-AYALA F, Dobano-Lopez C, Valero JG, Nadeu F, et al
    A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses.
    Leukemia. 2023 Apr 8. doi: 10.1038/s41375-023-01885.
    PubMed         Abstract available

  12. HEMMINKI K, Hemminki J, Forsti A, Sud A, et al
    Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment.
    Leukemia. 2023;37:854-863.
    PubMed         Abstract available

  13. KROONEN JS, de Graaf IJ, Kumar S, Remst DFG, et al
    Inhibition of SUMOylation enhances DNA hypomethylating drug efficacy to reduce outgrowth of hematopoietic malignancies.
    Leukemia. 2023;37:864-876.
    PubMed         Abstract available


    N Engl J Med

  14. SCHMIDT EP, Shepard JO, Liu L
    Case 11-2023: A 67-Year-Old Man with Mantle-Cell Lymphoma and Hypoxemia.
    N Engl J Med. 2023;388:1416-1423.
    PubMed        


    Oncol Rep

  15. WANG H, Xiong M, Hu Y, Sun Y, et al
    [Retracted] MicroRNA‑19b inhibits proliferation of gastric cancer cells by targeting B‑cell CLL/lymphoma 3.
    Oncol Rep. 2023;49:104.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: